The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP)

项目摘要 大西洋健康癌症联盟社区肿瘤学研究计划(AHCC-Corp)是第一个 新泽西州内的NCORP社区站点，结合了世界级的集体优势 提供社区肿瘤护理服务的医疗保健系统。AHC-Corp涵盖了地理上和 人口结构多样化的地区，占新泽西州人口的73%。AHC-Corp扩大了 NCORP网络由650万人组成；癌症发病率高于美国整体水平(477.5比441.2 每100,000个病例)。AHC-Corp的区域甚至进一步上升。 具体目标包括：​1)增加成人和儿童对非传染性疾病癌症预防、控制、 筛查和护理提供研究，以及由 国家临床试验网络(NCTN)和生物样品收集​。​这将通过以下方式完成 在新泽西州​创建了一个独特且史无前例的癌症护理联盟。该财团经历的​ 癌症研究人员在多个地点对成人和儿童癌症进行调查，其中包括三家儿童医院。 另外，联盟站点每年平均有130NCORP研究基地的​参与者，但 在ACC-Corp的领导和基础设施支持下，附属公司现在准备进一步 增加应计项目。​2)加强社区对​癌症控制和预防临床试验的参与 以及由NCORP​在美国癌症协会-​集水区进行的癌症护理提供研究。 将通过创新方法提高参与度，使医生、患者和 社区。​的发展主要包括社交媒体传播和互动的视频片段 Chatbot功能由自然语言处理提供支持，允许在 支持多种语言的癌症差异整合。此外，ahc-corp​有一个明确定义的 确定NCORP和NCTN试验激活优先级的流程，以及支持成功研究的程序 跨站点的应计和数据收集。​AHCCCorp还将支持和指导社区肿瘤学家 新泽西州中部和北部的其他医疗专家​，进一步提高癌症护理服务的能力 研究。​3)有助于开发和实施具有临床意义的研究 将不同人群的独特研究需求纳入AHC NCORP流域 领域，利用现有肿瘤学专科医生和其他供应商的专业知识 我们的附属网络。​拥有成熟的临床和研究专业知识，涵盖多种肿瘤类型和 将利用AHCC-Corp医生和其他提供者的研究模式来支持NCORP 通过​积极参与研究基地和其他NCORP范围的活动来实现总体规划目标 研究领导委员会。

Project Summary Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC-CORP) is the first NCORP Community Site within the state of New Jersey and combines the collective strengths of world-class healthcare systems with community oncology care delivery. AHCC-CORP covers a geographically and demographically diverse area representing 73% of New Jersey’s population. AHCC-CORP expands the NCORP network by 6.5M people; with a higher cancer incidence rate than the US as a whole (477.5 vs 441.2 cases per 100,000). Regions of AHCC-CORP are even further elevated. Specific Aims include: ​1) Increase adult and pediatric accruals to NCI cancer prevention, control, screening, and care delivery research studies, as well as treatment and imaging studies conducted by the National Clinical Trials Network (NCTN) and biospecimen collection​. ​This will be accomplished by creating a unique and unprecedented cancer care consortium in New Jersey​. ​The Consortium has experienced cancer investigators in adult and pediatric cancers across multiple sites, including three children's hospitals. Separately, Consortium sites annually accrue an average of 130 ​participants to NCORP Research Bases, but with the leadership and infrastructure support of AHCC-CORP, affiliates are now poised to even further increase accruals. ​2) Enhance community engagement in ​cancer control and prevention clinical trials and Cancer Care Delivery Research (CCDR) conducted by NCORP ​in the AHCC-CORP ​catchment area. Engagement will be enhanced through innovative approaches that effectively engage physicians, patients, and the community. Developments ​notably include video vignettes for social media dissemination and interactive chatbot capabilities powered by natural language processing, allowing recruitment/retention strategies in multiple languages in support of cancer disparities integration. Additionally, AHCC-CORP ​has a clearly-defined process for prioritizing NCORP and NCTN trials for activation, and procedures in support of successful study accrual and data collection across sites.​ AHCC-CORP will also support and mentor community oncologists and other medical specialists in central and northern New Jersey​, furthering capabilities in cancer care delivery research. ​3) Contribute to the development and implementation of clinically significant studies that incorporate the unique research needs of the diverse population within the AHCC NCORP catchment area, leveraging the expertise of established oncology specialty physicians and other providers within our affiliate network. ​The established clinical and research expertise, across multiple tumor types and research modalities, of AHCC-CORP physicians and other providers will be leveraged to support NCORP overarching programmatic goals through ​active involvement in Research Bases and other NCORP-wide research leadership committees.